GENPACT LIMITED
Here’s whether GENPACT LIMITED (G) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.35% over 10 days); RSI 61 — healthy momentum range; 3-month momentum positive (+16.4%); rising volume confirms the move (1.24x 30d avg). Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -16.6%. Currently 23.6% off its 52-week high. Score: +2/7.
G is trading below its 200-day MA ($37.87) — a key warning sign the longer-term trend is under pressure. An RSI of 61.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -16.6% compares to +20.5% for SPY (trailed the market by 37.1%). The current 23.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.